Nodular regenerative hyperplasia: A side effect of azathioprine in a patient with Crohn's disease;Noduläre regenerative hyperplasie als nebenwirkung von azathioprin bei morbus Crohn

Deutsche Medizinische Wochenschrift

Volumn 133, Issue 38, 2008, Pages 1897-1900

  Schumann, M ^a   Preiss, J C ^a   Loddenkemper, C ^a   Gunther U ^a   Somasundaram, R ^a   Siegmund, B ^a   Zeitz, M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Azathioprine; Crohn's disease; Hyperbilirubinemia; Icterus

Indexed keywords

AZATHIOPRINE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; CROHN DISEASE; DRUG WITHDRAWAL; HUMAN; HUMAN TISSUE; HYPERPLASIA; LABORATORY TEST; LIVER HISTOLOGY; PANCYTOPENIA;

ASCITES; AZATHIOPRINE; BLOOD CELL COUNT; CROHN DISEASE; DIAGNOSIS, DIFFERENTIAL; FATIGUE; FOCAL NODULAR HYPERPLASIA; HUMANS; IMMUNOSUPPRESSIVE AGENTS; JAUNDICE; LIVER; MALE; MIDDLE AGED; PANCYTOPENIA;

EID: 53849127854     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0028-1085573     Document Type: Article

References (14)

1. Connell WR, Kamm MA, Ritchie JK, Lennard-Jones JE. Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience. Gut 1993; 34: 1081-5
2. Croquelois A, Blindenbacher A, Terracciano L et al. Inducible inactivation of Notch1 causes nodular regenerative hyperplasia in mice. Hepatology 2005; 41: 487-96
3. Dubinsky MC. Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety. Clin Gastroenterol Hepatol 2004; 2: 731-43
4. Dubinsky MC, Vasiliauskas EA, Singh H et al. 6-thioguanine can cause serious liver injury in inflammatory bowel disease patients. Gastroenterology 2003; 125: 298-303
5. Ehmsen L, Marko C, Breidert M. [Portal vein hypertension during azathioprine therapy in patients with Crohn's disease - a frequent phenomenon?]. Dtsch Med Wochenschr 2008; 133: 950-3
6. Kandiel A, Fraser AG, Korelitz BI, Brensinger C, Lewis JD. Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine. Gut 2005; 54: 1121-5
7. Pearson DC, May GR, Fick GH, Sutherland LR. Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis. Ann Intern Med 1995; 123: 132-42
8. Qi R, An H, Yu Y et al. Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis. Cancer Res 2003; 63: 8323-9
9. Radomski JS, Chojnacki KA, Moritz MJ et al. Results of liver transplantation for nodular regenerative hyperplasia. Am Surg 2000; 66: 1067-70
10. Reshamwala PA, Kleiner DE, Heller T. Nodular regenerative hyperplasia: not all nodules are created equal. Hepatology 2006; 44: 7-14
11. Sandborn W, Sutherland L, Pearson D, May G, Modigliani R, Prantera C. Azathioprine or 6-mercaptopurine for inducing remission of Crohn's disease. Cochrane Database Syst Rev, 2000CD000545
12. Tiede I, Fritz G, Strand S et al. CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes. J Clin Invest 2003; 111: 1133-45
13. Vernier-Massouille G, Cosnes J, Lemann M et al. Nodular regenerative hyperplasia in patients with inflammatory bowel disease treated with azathioprine. Gut 2007; 56: 1404-9
14. Wanless IR. Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules. Hepatology 1990; 11: 787-97